Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Nicolas

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Genitourinary Cancer|November 25, 2018
Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?Benjamin L Taylor, Cathleen E Matrai, Ariana L Smith, et al.
World Journal of Urology|February 26, 2026
Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Journal of Inflammation (London, England)|August 15, 2025
Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Cancers|February 13, 2025
Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-AnalysisConor B Driscoll, Jordan M Rich, Dylan Isaacson, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Genitourinary Cancer|November 25, 2018
Gynecologic Organ Involvement During Radical Cystectomy for Bladder Cancer: Is It Time to Routinely Spare the Ovaries?Benjamin L Taylor, Cathleen E Matrai, Ariana L Smith, et al.
World Journal of Urology|February 26, 2026
Urologic malignancy risk with chronic tumor necrosis factor-alpha inhibitor (TNF-I) exposure: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Journal of Inflammation (London, England)|August 15, 2025
Long-term risk of de novo malignancy with tumor necrosis factor alpha (TNF) inhibitor immunosuppression: a multicenter, retrospective cohort studyConor B Driscoll, Jordan M Rich, Christopher Yang, et al.
Cancers|February 13, 2025
Tumor Necrosis Factor-Alpha Inhibitor Use and Malignancy Risk: A Systematic Review and Patient Level Meta-AnalysisConor B Driscoll, Jordan M Rich, Dylan Isaacson, et al.
Pageof 2